Pharmaceutical Microemulsions for Parenteral Delivery: From Bench to Bedside

Details information on the preformulation of drugs, formulation using quality by design (QbD) principles, and characterization of parenteral microemulsions for drug delivery. Explores the role of surfactants and cosurfactants in formulation, clinical aspects of parenteral microemulsion, regulatory perspectives and patents, etc.

Vivek P. Chavda, MPharm, is currently working as an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, Ahmedabad, Gujarat, India. Before joining academia, he served in the biologics industry for almost eight years in research and development with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy’s Laboratory (Hyderabad). He has more than 120 national and international publications, nearly 20 book chapters, and several book chapters. He has one patent in progress as well as numerous newsletter articles to his credit. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He earned his BPharm and MPharm degrees (with gold medals) at Gujarat Technological University, Gujarat, India.

Vandana B. Patravale, PhD, is a Professor of Pharmaceutics at the Institute of Chemical Technology, Mumbai, India. Her research interests include development of nano-carriers with a major emphasis on infectious diseases, cancer and neurodegenerative disorders, medical device development, nano-diagnostics, and nano-vaccines. She has over 200 refereed publications, two books, and over 25 book chapters to her credit. She holds 31 granted patents and has 14 patents in progress and two trademark registries to her credit. She is the Vice President of the Controlled Release Society (Indian Chapter) and the National Convenor of the Women’s Forum of the Association of Pharmaceutical Teachers of India. She is actively involved in the pharmaceutical industry and has transferred more than 20 technologies to various industries, including technology on drug-eluting stents, which is being marketed in more than 60 countries.